INBP
Integrated BioPharma, Inc.
Price Chart
Latest Quote
$0.18
+0.00 (+0.00%)
Current Price
| Previous Close | $0.18 |
| Open | $0.17 |
| Day High | $0.17 |
| Day Low | $0.17 |
| Volume | 1,000 |
Stock Information
| Shares Outstanding | 31.06M |
| Total Debt | $3.35M |
| Cash Equivalents | $5.83M |
| Revenue | $48.25M |
| Net Income | $-1.65M |
| Sector | Consumer Defensive |
| Industry | Packaged Foods |
| Market Cap | $5.59M |
| EPS (TTM) | $-0.05 |
| Exchange | OQX |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $3.10M |
| Sales | $48.25M |
| Income | $-1.65M |
| Book/sh | $0.61 |
| Cash/sh | $0.19 |
| Employees | 153 |
Financial Ratios
| Quick Ratio | 1.72 |
| Current Ratio | 3.25 |
| Debt/Eq | 17.63 |
Returns & Margins
| ROA | -2.98% |
| ROE | -8.40% |
| Gross Margin | 4.64% |
| Operating Margin | -10.73% |
| Profit Margin | -3.43% |
Ownership
| Insider Ownership | 68.43% |
| Institutional Ownership | 0.06% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 0.12 |
| P/B | 0.29 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.18 |
| SMA50 | $0.22 |
| SMA200 | $0.29 |
| RSI | 33.33 |
| ATR | 0.0107 |
| Shares Float | 7.22M |
| Volatility | 0.36 |
| Rel Volume | 0.21 |
Performance History
| Week | -5.26% |
| Month | -5.26% |
| Quarter | -40.00% |
| 6 Months | -41.94% |
| YTD | -51.35% |
| Year | -45.45% |
| 3 Years | -45.45% |
| 5 Years | -84.21% |
| 10 Years | +63.64% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $0.18 | 1,300 |
| 2026-06-23 | $0.18 | 10,000 |
| 2026-06-22 | $0.19 | 55,100 |
| 2026-06-18 | $0.19 | 0 |
| 2026-06-17 | $0.19 | 0 |
| 2026-06-16 | $0.19 | 0 |
| 2026-06-15 | $0.19 | 600 |
| 2026-06-12 | $0.18 | 0 |
| 2026-06-11 | $0.18 | 0 |
| 2026-06-10 | $0.18 | 0 |
| 2026-06-09 | $0.18 | 2,900 |
| 2026-06-08 | $0.18 | 5,900 |
| 2026-06-05 | $0.18 | 17,300 |
| 2026-06-04 | $0.18 | 2,300 |
| 2026-06-03 | $0.19 | 300 |
| 2026-06-02 | $0.19 | 0 |
| 2026-06-01 | $0.19 | 4,000 |
| 2026-05-29 | $0.18 | 8,100 |
| 2026-05-28 | $0.18 | 2,600 |
| 2026-05-27 | $0.18 | 11,500 |
| 2026-05-26 | $0.18 | 7,500 |
About Integrated BioPharma, Inc.
Integrated BioPharma, Inc., together with its subsidiaries, engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. The company operates through two segments, Contract Manufacturing and Other Business Lines. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment provides warehousing and fulfilment services; and distributes raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.
đ° Latest News
No news articles available at the moment. Check back later for updates on INBP.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $48,791,000 | $46,433,000 | $46,611,000 | $49,694,000 |
| Cost Of Revenue | $48,791,000 | $46,433,000 | $46,611,000 | $49,694,000 |
| Total Revenue | $54,353,000 | $50,317,000 | $50,672,000 | $56,246,000 |
| Operating Revenue | $54,353,000 | $50,317,000 | $50,672,000 | $56,246,000 |
| Expenses | ||||
| Total Expenses | $52,333,000 | $50,066,000 | $50,552,000 | $53,501,000 |
| Other Income Expense | $3,000 | $-1,000 | $-6,000 | $-20,000 |
| Other Non Operating Income Expenses | $3,000 | $-1,000 | $-6,000 | $35,000 |
| Net Non Operating Interest Income Expense | $39,000 | $18,000 | $-14,000 | $-128,000 |
| Operating Expense | $3,542,000 | $3,633,000 | $3,941,000 | $3,807,000 |
| Total Other Finance Cost | - | $-18,000 | $14,000 | $21,000 |
| Interest Expense | - | - | $40,000 | $107,000 |
| Interest Expense Non Operating | - | - | $40,000 | $107,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $808,000 | $112,000 | $-34,000 | $3,838,000 |
| Net Interest Income | $39,000 | $18,000 | $-14,000 | $-128,000 |
| Interest Income | $39,000 | $18,000 | - | - |
| Normalized Income | $808,000 | $112,000 | $-34,000 | $3,881,450 |
| Net Income From Continuing And Discontinued Operation | $808,000 | $112,000 | $-34,000 | $3,838,000 |
| Total Operating Income As Reported | $2,020,000 | $251,000 | $120,000 | $2,745,000 |
| Net Income Common Stockholders | $808,000 | $112,000 | $-34,000 | $3,838,000 |
| Net Income | $808,000 | $112,000 | $-34,000 | $3,838,000 |
| Net Income Including Noncontrolling Interests | $808,000 | $112,000 | $-34,000 | $3,838,000 |
| Net Income Continuous Operations | $808,000 | $112,000 | $-34,000 | $3,838,000 |
| Pretax Income | $2,062,000 | $268,000 | $100,000 | $2,597,000 |
| Interest Income Non Operating | $39,000 | $18,000 | - | - |
| Operating Income | $2,020,000 | $251,000 | $120,000 | $2,745,000 |
| Gross Profit | $5,562,000 | $3,884,000 | $4,061,000 | $6,552,000 |
| Special Income Charges | - | - | - | $0 |
| Per Share | ||||
| Diluted EPS | $0.03 | $0.00 | $-0.00 | $0.12 |
| Basic EPS | $0.03 | $0.00 | $-0.00 | $0.13 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $-11,550 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $3,289,000 | $1,472,000 | $1,274,000 | $3,593,000 |
| Reconciled Depreciation | $1,269,000 | $1,221,000 | $1,154,000 | $834,000 |
| EBITDA (Bullshit earnings) | $3,289,000 | $1,472,000 | $1,274,000 | $3,538,000 |
| EBIT | $2,020,000 | $251,000 | $120,000 | $2,704,000 |
| Diluted Average Shares | $31,168,372 | $30,873,681 | $29,949,610 | $32,113,681 |
| Basic Average Shares | $30,295,655 | $30,066,003 | $29,949,610 | $29,699,065 |
| Diluted NI Availto Com Stockholders | $808,000 | $112,000 | $-34,000 | $3,838,000 |
| Tax Provision | $1,254,000 | $156,000 | $134,000 | $-1,241,000 |
| Selling General And Administration | $3,542,000 | $3,633,000 | $3,941,000 | $3,807,000 |
| Total Unusual Items | - | - | $-8,000 | $-55,000 |
| Total Unusual Items Excluding Goodwill | - | - | $-8,000 | $-55,000 |
| Gain On Sale Of Security | - | - | $-8,000 | $-55,000 |
| Other Special Charges | - | - | - | - |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $20,317,000 | $19,238,000 | $18,861,000 | $18,575,000 |
| Total Assets | $24,901,000 | $26,207,000 | $25,431,000 | $25,250,000 |
| Total Non Current Assets | $6,138,000 | $8,332,000 | $9,059,000 | $8,624,000 |
| Other Non Current Assets | $52,000 | $56,000 | $57,000 | $49,000 |
| Non Current Deferred Assets | $3,337,000 | $4,601,000 | $4,726,000 | $4,798,000 |
| Non Current Deferred Taxes Assets | $3,337,000 | $4,601,000 | $4,726,000 | $4,798,000 |
| Current Assets | $18,763,000 | $17,875,000 | $16,372,000 | $16,626,000 |
| Other Current Assets | $356,000 | $286,000 | $284,000 | $352,000 |
| Inventory | $9,362,000 | $11,244,000 | $10,261,000 | $11,055,000 |
| Receivables | $5,430,000 | $4,668,000 | $4,511,000 | $4,888,000 |
| Accounts Receivable | $5,430,000 | $4,668,000 | $4,511,000 | $4,888,000 |
| Allowance For Doubtful Accounts Receivable | $-20,000 | $-1,000 | - | - |
| Gross Accounts Receivable | $5,450,000 | $4,669,000 | - | - |
| Cash Cash Equivalents And Short Term Investments | $3,615,000 | $1,677,000 | $1,316,000 | $331,000 |
| Cash And Cash Equivalents | $3,615,000 | $1,677,000 | $1,316,000 | $331,000 |
| Cash Financial | $3,615,000 | $1,677,000 | $1,316,000 | $331,000 |
| Non Current Prepaid Assets | - | - | - | $49,000 |
| Debt | ||||
| Total Debt | $1,015,000 | $1,798,000 | $2,672,000 | $2,055,000 |
| Long Term Debt And Capital Lease Obligation | $336,000 | $846,000 | $1,742,000 | $1,412,000 |
| Current Debt And Capital Lease Obligation | $679,000 | $952,000 | $930,000 | $643,000 |
| Long Term Debt | - | - | $7,000 | $53,000 |
| Current Debt | - | - | $42,000 | $133,000 |
| Other Current Borrowings | - | - | $42,000 | $32,000 |
| Net Debt | - | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $4,584,000 | $6,969,000 | $6,570,000 | $6,675,000 |
| Total Non Current Liabilities Net Minority Interest | $336,000 | $846,000 | $1,742,000 | $1,412,000 |
| Current Liabilities | $4,248,000 | $6,123,000 | $4,828,000 | $5,263,000 |
| Payables And Accrued Expenses | $3,569,000 | $5,171,000 | $3,898,000 | $4,620,000 |
| Payables | $2,267,000 | $2,510,000 | $2,266,000 | $3,209,000 |
| Accounts Payable | $2,267,000 | $2,510,000 | $2,266,000 | $3,209,000 |
| Equity | ||||
| Common Stock Equity | $20,317,000 | $19,238,000 | $18,861,000 | $18,575,000 |
| Total Equity Gross Minority Interest | $20,317,000 | $19,238,000 | $18,861,000 | $18,575,000 |
| Stockholders Equity | $20,317,000 | $19,238,000 | $18,861,000 | $18,575,000 |
| Retained Earnings | $-31,419,000 | $-32,227,000 | $-32,339,000 | $-32,305,000 |
| Other | ||||
| Treasury Shares Number | $34,900 | $34,900 | $34,900 | $34,900 |
| Ordinary Shares Number | $31,059,610 | $30,099,610 | $29,949,610 | $29,949,610 |
| Share Issued | $31,094,510 | $30,134,510 | $29,984,510 | $29,984,510 |
| Tangible Book Value | $20,317,000 | $19,238,000 | $18,861,000 | $18,575,000 |
| Invested Capital | $20,317,000 | $19,238,000 | $18,861,000 | $18,761,000 |
| Working Capital | $14,515,000 | $11,752,000 | $11,544,000 | $11,363,000 |
| Capital Lease Obligations | $1,015,000 | $1,798,000 | $2,672,000 | $1,869,000 |
| Total Capitalization | $20,317,000 | $19,238,000 | $18,861,000 | $18,628,000 |
| Treasury Stock | $99,000 | $99,000 | $99,000 | $99,000 |
| Additional Paid In Capital | $51,773,000 | $51,504,000 | $51,239,000 | $50,919,000 |
| Capital Stock | $62,000 | $60,000 | $60,000 | $60,000 |
| Common Stock | $62,000 | $60,000 | $60,000 | $60,000 |
| Long Term Capital Lease Obligation | $336,000 | $846,000 | $1,742,000 | $1,359,000 |
| Current Capital Lease Obligation | $679,000 | $952,000 | $930,000 | $510,000 |
| Current Accrued Expenses | $1,302,000 | $2,661,000 | $1,632,000 | $1,411,000 |
| Net PPE | $2,749,000 | $3,675,000 | $4,276,000 | $3,777,000 |
| Accumulated Depreciation | $-8,190,000 | $-7,901,000 | $-7,769,000 | $-7,444,000 |
| Gross PPE | $10,939,000 | $11,576,000 | $12,045,000 | $11,221,000 |
| Leases | $1,414,000 | $1,341,000 | $1,371,000 | $1,371,000 |
| Other Properties | $1,026,000 | $1,873,000 | $2,623,000 | $1,867,000 |
| Machinery Furniture Equipment | $7,249,000 | $7,112,000 | $6,801,000 | $6,733,000 |
| Land And Improvements | $1,250,000 | $1,250,000 | $1,250,000 | $1,250,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $901,000 | $907,000 | $1,254,000 | $1,440,000 |
| Work In Process | $2,736,000 | $2,449,000 | $2,148,000 | $1,759,000 |
| Raw Materials | $5,725,000 | $7,888,000 | $6,859,000 | $7,586,000 |
| Line Of Credit | - | - | $0 | $101,000 |
| Other Inventories | - | - | - | $270,000 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $1,860,000 | $390,000 | $1,116,000 | $3,605,000 |
| Operating Activities | ||||
| Operating Cash Flow | $2,065,000 | $943,000 | $1,232,000 | $4,091,000 |
| Cash Flow From Continuing Operating Activities | $2,065,000 | $943,000 | $1,232,000 | $4,091,000 |
| Operating Gains Losses | $4,000 | $1,000 | $34,000 | $-22,000 |
| Investing Activities | ||||
| Capital Expenditure | $-205,000 | $-553,000 | $-116,000 | $-486,000 |
| Investing Cash Flow | $-205,000 | $-553,000 | $-111,000 | $-465,000 |
| Cash Flow From Continuing Investing Activities | $-205,000 | $-553,000 | $-111,000 | $-465,000 |
| Financing Activities | ||||
| Financing Cash Flow | $78,000 | $-29,000 | $-136,000 | $-3,505,000 |
| Cash Flow From Continuing Financing Activities | $78,000 | $-29,000 | $-136,000 | $-3,505,000 |
| Other | ||||
| Repayment Of Debt | $-8,000 | $-42,000 | $-136,000 | $-3,539,000 |
| Interest Paid Supplemental Data | $47,000 | $42,000 | $41,000 | $113,000 |
| Income Tax Paid Supplemental Data | $82,000 | $37,000 | $0 | $471,000 |
| End Cash Position | $3,615,000 | $1,677,000 | $1,316,000 | $331,000 |
| Beginning Cash Position | $1,677,000 | $1,316,000 | $331,000 | $210,000 |
| Changes In Cash | $1,938,000 | $361,000 | $985,000 | $121,000 |
| Proceeds From Stock Option Exercised | $86,000 | $13,000 | $0 | $34,000 |
| Net Issuance Payments Of Debt | $-8,000 | $-42,000 | $-136,000 | $-3,539,000 |
| Net Long Term Debt Issuance | $-8,000 | $-42,000 | $-35,000 | $-1,466,000 |
| Long Term Debt Payments | $-8,000 | $-42,000 | $-35,000 | $-1,466,000 |
| Net PPE Purchase And Sale | $-205,000 | $-553,000 | $-115,000 | $-465,000 |
| Purchase Of PPE | $-205,000 | $-553,000 | $-116,000 | $-486,000 |
| Change In Working Capital | $-1,502,000 | $-744,000 | $-302,000 | $513,000 |
| Change In Other Current Liabilities | $-945,000 | $-902,000 | $-804,000 | $-501,000 |
| Change In Other Current Assets | $-92,000 | $-12,000 | - | - |
| Change In Payables And Accrued Expense | $-1,566,000 | $1,273,000 | $-700,000 | $-417,000 |
| Change In Accrued Expense | $-1,355,000 | $1,029,000 | $221,000 | $-199,000 |
| Change In Payable | $-211,000 | $244,000 | $-921,000 | $-218,000 |
| Change In Account Payable | $-211,000 | $244,000 | $-921,000 | $-218,000 |
| Change In Inventory | $1,882,000 | $-983,000 | $794,000 | $640,000 |
| Change In Receivables | $-781,000 | $-120,000 | $374,000 | $875,000 |
| Changes In Account Receivables | $-781,000 | $-120,000 | $374,000 | $875,000 |
| Other Non Cash Items | $-10,000 | $12,000 | $12,000 | $21,000 |
| Stock Based Compensation | $185,000 | $252,000 | $320,000 | $369,000 |
| Provisionand Write Offof Assets | $19,000 | $-36,000 | - | $-39,000 |
| Asset Impairment Charge | $28,000 | $0 | $3,000 | $13,000 |
| Deferred Tax | $1,264,000 | $125,000 | $72,000 | $-1,530,000 |
| Deferred Income Tax | $1,264,000 | $125,000 | $72,000 | $-1,530,000 |
| Depreciation Amortization Depletion | $1,269,000 | $1,221,000 | $1,154,000 | $834,000 |
| Depreciation And Amortization | $1,269,000 | $1,221,000 | $1,154,000 | $834,000 |
| Depreciation | $1,269,000 | $1,221,000 | $1,154,000 | $834,000 |
| Gain Loss On Sale Of PPE | $4,000 | $1,000 | $-1,000 | $-22,000 |
| Net Income From Continuing Operations | $808,000 | $112,000 | $-34,000 | $3,838,000 |
| Net Short Term Debt Issuance | - | $0 | $-101,000 | $-2,073,000 |
| Short Term Debt Payments | - | $0 | $-101,000 | $-2,073,000 |
| Net Business Purchase And Sale | - | $0 | $4,000 | $0 |
| Sale Of Business | - | $0 | $4,000 | $0 |
| Sale Of PPE | - | $0 | $1,000 | $21,000 |
| Change In Prepaid Assets | - | $-12,000 | $34,000 | $-84,000 |
| Unrealized Gain Loss On Investment Securities | - | $0 | $-27,000 | $55,000 |
| Gain Loss On Investment Securities | - | - | $35,000 | - |
| Issuance Of Debt | - | - | - | $54,618,000 |
| Short Term Debt Issuance | - | - | - | $54,618,000 |
| Long Term Debt Issuance | - | - | - | - |
Fetched: 2026-02-02